Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Bank of America downgrades Taylor Wimpey to 'neutral', sees near-term headwinds

(Sharecast News) - Bank of America downgraded Taylor Wimpey to 'neutral' from 'buy' on Tuesday and cut the price target 13% to 105p, pointing to near-term headwinds. "We still like their quality land bank, high presence among first time buyers and we believe the mid-term growth story is intact driven by a lower rate/planning reform," it said.

"However, we see some headwinds in the near term for this name: a slower-than-peers' progress in outlet opening, a softening 2Q market condition, fire safety issue only to be fixed by 2030, dividend payment is not comfortably covered, and consensus on FY26 margin expansion is optimistic, in our view."

Bank of America said Taylor Wimpey's 2026E multiple is at circa 0.8x P/B and 11x P/E. This is low but is largely in line with what the one-year forward return on equity is implying at 0.9x and 11.8x respectively, it said.

At 0905 BST, the shares were down 3.2% at 92.98p,

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.